National Cancer Institute - U.S. National Institutes of Health - www.cancer.govSkip navigationNational Cancer Institute - U.S. National Institutes of Health - www.cancer.govClinical Trials at NIH - Be part of the cure
National Cancer Institute - U.S. National Institutes of Health - www.cancer.gov
Clinical Trials at NIH Home

Search for Clinical Trials at NIH

The NCI Center for Cancer Research (CCR) conducts more than 150 cancer clinical trials at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. Cancer clinical trials that take place at the NIH Clinical Center are open to patients with cancer, regardless of where they live in the United States.

Go to Search Page

There are 5 clinical trials at NIH that match your search criteria


  • Cancer by type/disease: Kaposi Sarcoma

  
Trial and Protocol Number
Kaposi Sarcoma
Principal InvestigatorReferral Contact
Phase II
A Phase I/II Study of the Safety, Pharmacokinetics and Efficacy of Pomalidomide (CC-4047) in the Treatment of Kaposi Sarcoma in Individuals With or Without HIV
NCI-12-C-0047, NCT01495598
Robert Yarchoan
301-496-8959
Kathy Wyvill
301-496-8959
1-800-243-2732 ext. 4 (Toll Free)
wyvillk@mail.nih.gov
Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi’s Sarcoma
NCI-09-C-0130, NCT00923936
Robert Yarchoan
301-496-8959
Kathy Wyvill
301-496-8959
1-800-243-2732 ext. 4 (Toll Free)
wyvillk@mail.nih.gov


  
Trial and Protocol Number
Multicentric Castleman Disease and Associated Conditions
Principal InvestigatorReferral Contact
Phase II
Pilot Study of Tocilizumab in Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Multicentric Castleman Disease
NCI-11-C-0233, NCT01441063
Thomas Uldrick
301-496-8959
Karen Aleman
301-496-8959
1-800-243-2732 ext. 4 (Toll Free)
alemank@mail.nih.gov
No Phase
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS) Incorporating Pilot Evaluation of KSHV Targeted Therapies
NCI-11-C-0220, NCT01419561
Robert Yarchoan
301-496-8959
Kathy Wyvill
301-496-8959
1-800-243-2732 ext. 4 (Toll Free)
wyvillk@mail.nih.gov
Targeted Oncolytic Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman’s Disease With Laboratory and Clinical Correlates of Disease Activity
NCI-04-C-0275, NCT00099073
Robert Yarchoan
301-496-8959
Karen Aleman
301-496-8959
1-800-243-2732 ext. 4 (Toll Free)
alemank@mail.nih.gov


For additional studies that may be appropriate for your disease type, please search under Solid Tumor.

Back to Top
Health and Human Services National Institutes of Health National Cancer Institute USA.gov